Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the Brain
Saul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Cancer Research Communications
|
March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells
Renate Starr, Brenda Aguilar, Diana Gumber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood
|
September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E Brown, Behnam Badie, Michael E Barish, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells
Cheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cell Stem Cell
|
March 12, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
The New England Journal of Medicine
|
December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E Brown, Darya Alizadeh, Renate Starr, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the Brain
Saul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Cancer Research Communications
|
March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells
Renate Starr, Brenda Aguilar, Diana Gumber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood
|
September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E Brown, Behnam Badie, Michael E Barish, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells
Cheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cell Stem Cell
|
March 12, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
The New England Journal of Medicine
|
December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E Brown, Darya Alizadeh, Renate Starr, et al.
Page
of 5